Clinical Trial Update: Phase I/IIa AdCD40L Immunogene Therapy for Malignant Melanoma and Other Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update summarizes the completed Phase I/IIa study of AdCD40L immunogene therapy for malignant melanoma (and other solid tumors), including p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• AdCD40L (adenovirus-delivered CD40 ligand gene therapy)

Snippet

Sponsor: Uppsala University | Conditions: Malignant Melanoma | Phase 1, Phase 2 | Status: COMPLETED